APA (7th ed.) Citation

TFD, R., CS, M., MB, S., A, B., SS, C., VS, F., . . . R, H. (2021). Repurposing of escitalopram oxalate and clonazepam in combination with ciprofloxacin and sulfamethoxazole-trimethoprim for treatment of multidrug-resistant microorganisms and evaluation of the cleavage capacity of plasmid DNA. Canadian journal of microbiology, 67(8), 599. https://doi.org/10.1139/cjm-2020-0546

Chicago Style (17th ed.) Citation

TFD, Rosa, et al. "Repurposing of Escitalopram Oxalate and Clonazepam in Combination with Ciprofloxacin and Sulfamethoxazole-trimethoprim for Treatment of Multidrug-resistant Microorganisms and Evaluation of the Cleavage Capacity of Plasmid DNA." Canadian Journal of Microbiology 67, no. 8 (2021): 599. https://doi.org/10.1139/cjm-2020-0546.

MLA (9th ed.) Citation

TFD, Rosa, et al. "Repurposing of Escitalopram Oxalate and Clonazepam in Combination with Ciprofloxacin and Sulfamethoxazole-trimethoprim for Treatment of Multidrug-resistant Microorganisms and Evaluation of the Cleavage Capacity of Plasmid DNA." Canadian Journal of Microbiology, vol. 67, no. 8, 2021, p. 599, https://doi.org/10.1139/cjm-2020-0546.